Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BioNexus Gene Lab Corp ( (BGLC) ) has shared an announcement.
BioNexus Gene Lab Corp. has appointed Ms. Chong Set Fui as the new Chief Financial Officer and Principal Financial Officer, effective June 17, 2025. With over 25 years of financial leadership experience, Ms. Chong will also serve as CFO of the company’s subsidiary, MRNA Scientific Sdn. Bhd. This strategic appointment, recommended by the Nomination and Corporate Governance Committee, marks a significant step in strengthening the company’s financial oversight and compliance with U.S. federal securities laws and Nasdaq rules.
More about BioNexus Gene Lab Corp
Average Trading Volume: 670,542
Technical Sentiment Signal: Sell
Current Market Cap: $5.16M
For detailed information about BGLC stock, go to TipRanks’ Stock Analysis page.